Korean ECM heads for six year high with chunky IPOs

By Jonathan Breen
22 Sep 2016

South Korea’s IPO market is on track for a surge of issuance, as Doosan Bobcat and Samsung BioLogics prepare to list in the fourth quarter. Mid-caps are also lining up to float, giving a fillip to the country’s equity capital markets. Jonathan Breen reports.

So far this year there have been $1.8bn of IPOs in South Korea, according to Dealogic. But $1.2bn of that has come from deals below $100m. In comparison, during the same period of 2015, companies raised $2.2bn in IPOs — but just $752m was from listings smaller than ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial